As a step toward designing the first effective anti-HIV vaccine, scientists are reporting new insights into how a family of rare, highly potent antibodies bind to HIV, the virus that causes AIDS, and neutralize it — stop it from infecting human cells. They recently described the antibodies, which were isolated from people infected with HIV and can neutralize a wide range of HIV strains.